BioNTech, Fosun Pharma Begin Clinical Trial Of MRNA-based COVID-19 Vaccine Candidate In China

, , Comments Off on BioNTech, Fosun Pharma Begin Clinical Trial Of MRNA-based COVID-19 Vaccine Candidate In China

(RTTNews) – BioNTech SE (BNTX) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd announced Wednesday that the first 72 participants have already been dosed with BNT162b1 following IND approval by the …
( read original story …)